Cart
sales@molnova.com
FASN-IN-1
CAS No. 1808260-84-5
FASN-IN-1( TVB-2460 )
Catalog No. M26213 CAS No. 1808260-84-5
FASN-IN-1 is a fatty acid synthase (FASN) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 132 | In Stock |
|
| 5MG | 124 | In Stock |
|
| 10MG | 212 | In Stock |
|
| 25MG | 359 | In Stock |
|
| 50MG | 518 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFASN-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionFASN-IN-1 is a fatty acid synthase (FASN) inhibitor.
-
DescriptionFASN-IN-1 is a fatty acid synthase (FASN) inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsTVB-2460
-
PathwayMetabolic Enzyme/Protease
-
TargetFatty Acid Synthase
-
RecptorNMDA receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1808260-84-5
-
Formula Weight395.54
-
Molecular FormulaC18H25N3O3S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (252.82 mM)
-
SMILESCC[C@H](C)C(=O)Nc1nc(cs1)-c1ccc(cc1)S(=O)(=O)N(CC)CC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kondori NR, Paul P, Robbins JP, Liu K, Hildyard JCW, Wells DJ, de Belleroche JS. Focus on the Role of D-serine and D-amino Acid Oxidase in Amyotrophic Lateral Sclerosis/Motor Neuron Disease (ALS). Front Mol Biosci. 2018 Feb 13;5:8.
molnova catalog
related products
-
Gibberllin A7
Gibberillic acids (GA) are important plant growth hormones that promote plant cell growth and elongation. Gebberillins promote rapid stem and root growth, induce mitotic division and initiate (break dormancy) and increase seed germination rates.
-
FT113
FT113 is a novel potent inhibitor of fatty acid synthase (fasn IC50 : 213 nM)and exhibits anti-cancer activity.
-
FASN-IN-2
FASN-IN-2 is a Fatty Acid Synthase (FASN) inhibitor(IC50 of 0.052 μM and an EC50 of 0.072 μM),with potential antineoplastic activity.?TVB-2640 is an orally bioavailable fatty acid synthase (FASN) inhibitor, with potential antineoplastic activity.
